Patents by Inventor Harvey J. Berger

Harvey J. Berger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5046499
    Abstract: The invention pertains to a method quantitative localization of antimyosin uptake in the myocardium of a patient as an indication of myocardial infarction from a plurality of planar projections displayed simultaneously. The invention also pertains to a method for screening patients with chest pain due to myocardial ischemia to identify patients having a high risk of developing myocardial infarction.
    Type: Grant
    Filed: June 13, 1988
    Date of Patent: September 10, 1991
    Assignee: Centocor, Inc.
    Inventor: Harvey J. Berger
  • Patent number: 5026537
    Abstract: This invention pertains to a method of imaging atherosclerotic plaque using radiolabeled monoclonal antibodies that are specific for activated platelets or activated endothelial cells. The method is capable of determining the site of endothelial injury. This method involves the administration of a platelet-specific labeled monoclonal antibody or antibody fragment to a patient. The antibody is allowed to accumulate at the plaque site and the plaque is then scanned with a photoscanner. The detected signals are then converted into an image of the plaque.
    Type: Grant
    Filed: April 6, 1989
    Date of Patent: June 25, 1991
    Assignee: Centocor, Inc.
    Inventors: Peter E. Daddona, Harvey J. Berger, Rodger P. McEver
  • Patent number: 5024829
    Abstract: A method for instantaneous imaging of coronary thrombi is disclosed. A radiolabeled, thrombus-specific antibody or antibody fragment is administered into a coronary artery and the label is detected to obtain a visual image of the thrombus.
    Type: Grant
    Filed: November 21, 1988
    Date of Patent: June 18, 1991
    Assignee: Centocor, Inc.
    Inventors: Harvey J. Berger, Jamshid Maddahi, Daniel Berman
  • Patent number: 4952393
    Abstract: Method using technetium-99m imaging agents for the study, detection or diagnosis of ischemic, infarcted or diseased tissue. The imaging agents comprise a complex of technetium-99 m and glucarate.
    Type: Grant
    Filed: October 7, 1988
    Date of Patent: August 28, 1990
    Assignee: The General Hospital Corporation
    Inventors: Harvey J. Berger, Ban A. Khaw, Koon Y. Pak, H. William Strauss